AT

Antibody Therapeutics

Antibody Therapeutics is the official journal of ChAbS and publishes research in the field of therapeutic antibodies. The journal is fully open access and highlights impact metrics including a 2024 Impact Factor of 4.5 and a 2024 CiteScore of 8.4.

Looking to publish in Antibody Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology
Impact Factor 4.5
Quartile Q2
Open Access Type Hybrid
eISSN 2516-4236
Invitation Only No
Cost Range There is usually an Article Processing Charge for publication in fully open access journals, and authors usually pay an APC for gold open access in hybrid journals. Some diamond open access journals publish for free.

Submission Instructions

Antibody Therapeutics accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Research Articles must include an abstract written in English. Abstract must be no more than 250 words.
Manuscript Manuscript must not exceed 5000 words excluding the abstract, references, and figures/tables. Research Articles must include Title page, Abstract, Keywords, Introduction, Materials and methods, and Results sections. Manuscript must include a Statement of Significance of 50 words or fewer on the title page, 3–5 keywords, and Funding, conflict-of-interest, data availability, ethics and consent, and animal research statements.
References Research Articles must include no more than 50 references. References must be formatted in Oxford SciMed style. References must be cited in the text by sequential number in order of appearance and listed numerically, with journal names abbreviated in Chemical Abstracts style and full article titles provided.
Figures & Tables Research Articles must include no more than 7 tables, figures, and images combined. Tables and figures must be numbered consecutively, cited in the text, accompanied by legends, and data in the text should not be repeated extensively in captions or footnotes.
Reformat to Antibody Therapeutics using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Reviews must include an unstructured abstract written in English. Abstract must be up to 250 words. Abstract must be unstructured.
Manuscript Manuscript must not exceed 5000 words excluding the abstract, references, and figures/tables. Manuscript must include a Statement of Significance of 50 words or fewer on the title page, 3–5 keywords, and Funding, conflict-of-interest, and data availability statements, with funding declared under a separate subheading including specific grant numbers.
References References must be 150 or fewer. References must be formatted in Oxford SciMed style. References must be cited in the text by sequential number in order of appearance and listed numerically, with journal names abbreviated in Chemical Abstracts style and full article titles provided.
Figures & Tables Reviews must include 5 or fewer tables, figures, or images. Tables and figures must be numbered consecutively, cited in the text, accompanied by legends, and text data should not be repeated extensively in captions or footnotes.
Reformat to Antibody Therapeutics using Livewrite Premium

Mini Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required. Abstract must be up to 150 words. Abstract must be unstructured.
Manuscript Manuscript must not exceed 3,000 words. The title page must include a Statement of Significance of 50 words or fewer, the manuscript must include 3–5 keywords, and Funding, conflict-of-interest, and data availability statements must be included, with funding declared under a separate subheading including specific grant numbers.
References References must be 50 or fewer. References must be formatted in Oxford SciMed style. References must be cited in the text by sequential number in order of appearance and listed numerically, with journal names abbreviated in Chemical Abstracts style and full article titles provided.
Figures & Tables There may be up to 3 figures and/or tables. Figures and tables must be numbered consecutively, cited in the text, and accompanied by legends.
Reformat to Antibody Therapeutics using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required for Brief Reports. Abstract must be no more than 150 words. Abstract must be unstructured and written in English.
Manuscript Manuscript must not exceed 2,000 words excluding the abstract, references, and figures/tables. Manuscript must include Title page, Abstract, Keywords, Introduction, Materials and methods, Results, Discussion, Acknowledgements, References, Figure Legends, and Tables. Manuscript must include a 50-word-or-fewer Statement of Significance on the title page, 3–5 keywords, and Funding, conflict-of-interest, data availability, Ethics and consent, and Animal Research Statement sections.
References References must be 25 or fewer. References must be formatted in Oxford SciMed style. References must be cited in the text by sequential number in order of appearance and listed numerically with journal names abbreviated in Chemical Abstracts style and full article titles provided.
Figures & Tables Brief Reports may include up to 3 figures and/or tables. Figures and tables must be numbered consecutively, cited in the text, and accompanied by legends, and alt text must be provided under each figure legend in the main manuscript file.
Reformat to Antibody Therapeutics using Livewrite Premium

Recent Publications

Subcutaneous Administration of Antibody–Drug Conjugates: Current Challenges, Emerging Opportunities, and Future Perspectives

Steven Ren, Shawn Shouye Wang, Frank Yunsong Li

10.1093/abt/tbag028
View Publication

From T Cell Engagers to Next-Generation Immune Cell Engagers for Cancer Immunotherapy

Zaopeng Yang, Yang-Xin Fu

10.1093/abt/tbag030
View Publication

Design and Therapeutic Rationale of Antibody-Peptide Conjugates: Insights from Maridebart Cafraglutide (AMG133) and Emerging Applications

Junming Yie, Zongchun Mou, Xiaohong Liu

10.1093/abt/tbag029
View Publication

Efficacy of IgY on Helicobacter pylori eradication and improvement of clinical symptoms: a randomized double-blind clinical trial

Zahra Esmaeili, Sara Kamal Shahsavar, Elham Khosravi, Hamid Ariannejad, Mohammadreza Nassiri, Ali Beheshti Namdar, Mitra Ahadi, Ramin Sadeghi, Vahid Reza Dabbagh, Faezeh Sabet Birjandi, Majid Khadem Rezaiyan, Kiarash Ghazvini

10.1093/abt/tbag025
View Publication

Structure and function of therapeutic antibodies approved by the US FDA in 2025

William R Strohl

10.1093/abt/tbag027
View Publication

Frequently asked questions

How long does it take to publish?

Accepted Manuscript is published within one week after acceptance and signing of the publishing agreement. Advance Access publishes papers online soon after acceptance.

Reformat to Antibody Therapeutics using Livewrite Premium

Is a cover letter required?

A cover letter is required to disclose related or similar preprints, dissertations, manuscripts, published papers, and reports, and to explain how the submitted manuscript differs. Use of AI should be disclosed in cover letters to editors.

Reformat to Antibody Therapeutics using Livewrite Premium

What are the publication costs?

There is usually an Article Processing Charge for publication in fully open access journals, and authors usually pay an APC for gold open access in hybrid journals. Some diamond open access journals publish for free.

Reformat to Antibody Therapeutics using Livewrite Premium

Research Topics

Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research Protein purification and stability HER2/EGFR in Cancer Research SARS-CoV-2 and COVID-19 Research Glycosylation and Glycoproteins Research Immunotherapy and Immune Responses Viral Infectious Diseases and Gene Expression in Insects vaccines and immunoinformatics approaches Transgenic Plants and Applications Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction Biosimilars and Bioanalytical Methods Toxin Mechanisms and Immunotoxins Advanced Biosensing Techniques and Applications T-cell and B-cell Immunology Phagocytosis and Immune Regulation COVID-19 Clinical Research Studies Peptidase Inhibition and Analysis Bacteriophages and microbial interactions Biochemical and Structural Characterization Radiopharmaceutical Chemistry and Applications Click Chemistry and Applications Galectins and Cancer Biology Virus-based gene therapy research

Related Journals

AR
Aids Reviews PERMANYER PUBL
CA
Clinical And Experimental Immunology Oxford University Press
IB
Inflammatory Bowel Diseases Oxford University Press
TA
Transplantation And Cellular Therapy Elsevier BV
AA
Allergy Asthma & Immunology Research KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
II
International Immunopharmacology Elsevier BV